These conditions often go hand in hand, fueling complications such as cardiovascular disease, fatty liver disease, and metabolic syndrome
Think of it as both a builder and a bodyguard for your skin cells
Toripalimab is being proposed as a first-line, second-line or greater treatment for metastatic or recurrent NPC
Manufacturer: Hackshot s.r.o., Czech Republic
We advise against the use of these medications for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
Caution is advised in patients with a history of pancreatitis, and these medications should be avoided during pregnancy or discontinued well before planned conception (e.g., 2 months before planned pregnancy for semaglutide based on its half-life)